News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ResMed Inc.
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
June 10, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
May 23, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
May 16, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the RBCCM Global Healthcare Conference
May 07, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
April 25, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
April 04, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
March 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
March 06, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
February 12, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
January 24, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
January 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
December 20, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Secures Significant Victory in Patent Fight Against New York University
December 11, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Adopts New Operating Model to Accelerate Long-term Growth
November 09, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
October 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
October 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in Upcoming Conferences
September 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
August 03, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
July 06, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
July 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
June 08, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
May 25, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
May 02, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
April 27, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
April 06, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Chief Administrative Officer and Global General Counsel to Retire
March 30, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
March 15, 2023
From
ResMed Inc.
Via
GlobeNewswire
Tickers
ASX:RMD
RMD
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close